Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.45 |
| ▸ | FABP7 | O15540 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29729550 | 1.00 | POLB (0.47) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL6922053 | 0.95 | POLB (0.44) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL28263416 | 0.92 | TSHR (0.45) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL13327274 | 0.90 | POLB (0.52) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL22397770 | 0.90 | POLB (0.52) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL15636439 | 0.87 | KMT2A (0.45) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL30824716 | 0.87 | TSHR (0.50) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL30555288 | 0.87 | TSHR (0.50) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL8222797 | 0.87 | TSHR (0.50) | POLBKMT2AFABP5FABP7L3MBTL1 | |
| SCHEMBL31220527 | 0.85 | TSHR (0.52) | POLBKMT2AFABP5FABP7L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1934561-B1 | IMPROVED TIME/TEMPERATURE INDICATORS | SUN CHEMICAL CORP (US) | 2018-11-07 | — | — | EP | claimed |
| US-20080269050-A1 | Time/Temperature Indicators | SUN CHEMICAL CORPORATION (US) | 2008-10-30 | — | — | US | claimed |
| EP-1934561-A1 | IMPROVED TIME/TEMPERATURE INDICATORS | Sun Chemical Corporation (US) | 2008-06-25 | — | — | EP | claimed |
| WO-2007035365-A1 | IMPROVED TIME/TEMPERATURE INDICATORS | SUN CHEMICAL CORPORATION (US) | 2007-03-29 | — | — | WO | claimed |
| WO-2006091465-A1 | TIME/TEMPERATURE INDICATORS, THEIR PREPARATION AND USE | SUN CHEMICAL CORPORATION (US) | 2006-08-31 | — | — | WO | claimed |
| WO-2006091464-A1 | IMPROVED TIME/ TEMPERATURE INDICATORS | SUN CHEMICAL CORPORATION (US) | 2006-08-31 | — | — | WO | claimed |
| US-20260144788-A1 | COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF | UBIX THERAPEUTICS, INC. (KR) | 2026-05-28 | — | — | US | disclosed |
| EP-4606799-A1 | COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF | Ubix Therapeutics, Inc. (KR) | 2025-08-27 | — | — | EP | disclosed |
| EP-4592275-A2 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | Redwood Bioscience, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-3074010-B1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | REDWOOD BIOSCIENCE INC (US) | 2025-05-14 | — | — | EP | disclosed |
| US-20250121083-A1 | Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) Antibody-Maytansine Conjugates and Methods of Use Thereof | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2025-04-17 | — | — | US | disclosed |
| US-12215080-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | REDWOOD BIOSCIENCE, INC. (US) | 2025-02-04 | — | — | US | disclosed |
| CN-119264119-A | Preparation method and application of FLT3 degradation agent based on pyrazinecarboxamide skeleton | 中国科学院上海有机化学研究所 | 2025-01-07 | — | — | CN | disclosed |
| WO-2002081435-A1 | SULPHONES WHICH MODULATE THE ACTION OF GAMMA SECRETASE | MERCK SHARP & DOHME LIMITED (GB) | 2002-10-17 | — | — | WO | disclosed |
| US-6384065-B1 | CONTROL THE FUNCTIONS OF PROTEINS SUCH AS ENZYMES AND RECEPTOR FORTREATING INFLAMMATORY DISEASES SUCH AS RHEUMATOID ARTHRITIS, | TOYAMA CHEMICAL CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| US-6344449-B1 | HEADACHE AND MORPHINE DEPENDENCE | DR. KARL THOMAE GMBH (DE) | 2002-02-05 | — | — | US | disclosed |
| US-20010036946-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | RUDOLF KLAUS (DE) | 2001-11-01 | — | — | US | disclosed |
| EP-1076056-A1 | NOVEL SPIRO COMPOUNDS OR SALTS THEREOF AND PREVENTIVES/REMEDIES FOR AUTOIMMUNE DISEASES AND AP-1 INHIBITORS CONTAINING THE SAME | TOYAMA CHEMICAL CO., LTD. (JP) | 2001-02-14 | — | — | EP | disclosed |
| EP-0927192-A1 | MODIFIED AMINOACIDS, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND METHOD FOR THEIR PRODUCTION | Dr. Karl Thomae GmbH (DE) | 1999-07-07 | — | — | EP | disclosed |
| WO-1998011128-A1 | MODIFIED AMINOACIDS, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND METHOD FOR THEIR PRODUCTION | DR. KARL THOMAE GMBH (DE) | 1998-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144788-A1 | COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF | PTPN6, PTPN1, PTPN11 | POLB 4113/4885KMT2A 2438/4885FABP5 1538/4885 |
| US-12215080-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | DNPEP, QPCT, PDS5A | POLB 3676/4885KMT2A 1630/4885FABP5 2313/4885 |
| US-20250121083-A1 | Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) Antibody-Maytansine Conjugates and Methods of Use Thereof | TACR3, CASR, CAMK2D | POLB 4883/4885KMT2A 3623/4885FABP5 2641/4885 |
| US-20010036946-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, SRMS, OPRM1 | POLB 2814/4885KMT2A 2655/4885FABP5 2817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.